The inflammasomes: Guardians of the body

Annual Review of Immunology

Volumn 27, Issue , 2009, Pages 229-265

  Martinon, Fabio ^a   Mayor, Annick ^b   Tschopp, Jürg ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Adjuvanticity; Danger signal; Inflammation; Innate immunity; NOD like receptors

Indexed keywords

ADAPTOR PROTEIN; ADENOSINE TRIPHOSPHATE; ALUMINUM HYDROXIDE; ANTHRAX TOXIN; APOPTOSOME; ASBESTOS; BACTERIAL TOXIN; CASPASE; CHEMOKINE; CRYOPYRIN; CYTOKINE; CYTOPLASM PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOLOGICAL ADJUVANT; INFLAMMASOME; INTERFERON REGULATORY FACTOR 3; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 18; INTERLEUKIN 1BETA; MEMBRANE RECEPTOR; MULTIPROTEIN COMPLEX; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; POLYPEPTIDE ANTIBIOTIC AGENT; PORE FORMING CYTOTOXIC PROTEIN; REACTIVE OXYGEN METABOLITE; SILICON DIOXIDE; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG; URIC ACID;

ADAPTIVE IMMUNITY; ADULT ONSET STILL DISEASE; AEROMONAS HYDROPHILA; APOPTOSIS; AUTOIMMUNE DISEASE; BACTERIAL ARTHRITIS; BEHCET DISEASE; CELL DISRUPTION; CINCA SYNDROME; CLINICAL FEATURE; CONTACT DERMATITIS; CYTOPLASM; DISEASE ASSOCIATION; ENZYME ACTIVATION; FAMILIAL COLD AUTOINFLAMMATORY SYNDROME; FAMILIAL MEDITERRANEAN FEVER; GENE EXPRESSION REGULATION; GOUT; HUMAN; HYDATIDIFORM MOLE; HYPERIMMUNOGLOBULINEMIA D AND PERIODIC FEVER SYNDROME; INFLAMMATION; INFLAMMATORY DISEASE; INNATE IMMUNITY; JUVENILE RHEUMATOID ARTHRITIS; LISTERIA MONOCYTOGENES; METABOLIC STRESS; MICROORGANISM; MOLECULAR EVOLUTION; MOLECULAR RECOGNITION; MOLECULAR SENSOR; MUCKLE WELLS SYNDROME; NONHUMAN; PAPA SYNDROME; PNEUMONIA; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN STRUCTURE; PSEUDOGOUT; REVIEW; SCHNITZLER SYNDROME; SIGNAL TRANSDUCTION; SKIN INFLAMMATION; STAPHYLOCOCCUS AUREUS; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED PERIODIC SYNDROME; VACCINATION; VITILIGO;

ANIMALS; AUTOIMMUNE DISEASES; CARRIER PROTEINS; HUMANS; IMMUNITY, INNATE; INFLAMMATION; INTERLEUKIN-18; INTERLEUKIN-1BETA; MICE; NOD SIGNALING ADAPTOR PROTEINS; REACTIVE OXYGEN SPECIES; RNA HELICASES; TOLL-LIKE RECEPTORS; URIC ACID;

EID: 66749174867     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.021908.132715     Document Type: Review

References (261)

1. Basset C, Holton J, O'Mahony R, Roitt I. 2003. Innate immunity and pathogen-host interaction. Vaccine 21(Suppl. 2):S12-23
2. Medzhitov R, Janeway CA. 1997. Innate immunity: impact on the adaptive immune response. Curr. Opin. Immunol. 9:4-9
3. Medzhitov R, Janeway CA. 2002. Decoding the patterns of self and nonself by the innate immune system. Science 296:298-300
4. Janeway CA. 1992. The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol. Today 13:11-16
5. Matzinger P. 2002. The danger model: a renewed sense of self. Science 296:301-5
6. Seong SY, Matzinger P. 2004. Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. Nat. Rev. Immunol. 4:469-78
7. Ishii KJ, Suzuki K, Coban C, Takeshita F, Itoh Y, et al. 2001. Genomic DNA released by dying cells induces the maturation of APCs. J. Immunol. 167:2602-7
8. Martinon F, Pétrilli V, Mayor A, Tardivel A, Tschopp J. 2006. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440:237-41
9. Medzhitov R. 2008. Origin and physiological roles of inflammation. Nature 454:428-35
10. Kawai T, Akira S. 2007. TLR signaling. Semin. Immunol. 19:24-32
11. O'Neill LA, Bowie AG. 2007. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat. Rev. Immunol. 7:353-64
12. Gay NJ, Gangloff M. 2007. Structure and function of Toll receptors and their ligands. Annu. Rev. Biochem. 76:141-65
13. Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, et al. 2004. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5:730-37
14. Sumpter R, Loo YM, Foy E, Li K, Yoneyama M, et al. 2005. Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I. J. Virol. 79:2689-99
15. Andrejeva J, Childs KS, Young DF, Carlos TS, Stock N, et al. 2004. The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-β promoter. Proc. Natl. Acad. Sci. USA 101:17264-69
16. Meylan E, Curran J, Hofmann K, Moradpour D, Binder M, et al. 2005. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437:1167-72
17. Johnson CL, Gale M. 2006. CARD games between virus and host get a new player. Trends Immunol. 27:1-4
18. Seth RB, Sun L, Ea CK, Chen ZJ. 2005. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-κB and IRF 3. Cell 122:669-82
19. Martinon F, Tschopp J. 2005. NLRs join TLRs as innate sensors of pathogens. Trends Immunol. 26:447-54
20. Kufer T, Fritz JH, Philpott DJ. 2005. NACHT-LRR proteins (NLRs) in bacterial infection and immunity. Trends Microbiol. 13:381-88
21. Bella J, Hindle KL, McEwan PA, Lovell SC. 2008. The leucine-rich repeat structure. Cell Mol. Life Sci. 65(15):2307-33
22. Liu L, Botos I, Wang Y, Leonard JN, Shiloach J, et al. 2008. Structural basis of Toll-like receptor 3 signaling with double-stranded RNA. Science 320:379-81
23. Brodsky I, Medzhitov R. 2007. Two modes of ligand recognition by TLRs. Cell 130:979-81
24. Leipe DD, Koonin EV, Aravind L. 2004. STAND, a class of P-loop NTPases including animal and plant regulators of programmed cell death: multiple, complex domain architectures, unusual phyletic patterns, and evolution by horizontal gene transfer. J. Mol. Biol. 343:1-28
25. Martinon F, Tschopp J. 2004. Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell 117:561-74
26. Faustin B, Lartigue L, Bruey JM, Luciano F, Sergienko E, et al. 2007. Reconstituted NALP1 inflammasome reveals two-step mechanism of caspase-1 activation. Mol. Cell 25:713-24
27. Park HH, Lo YC, Lin SC, Wang L, Yang JK, Wu H. 2007. The death domain superfamily in intracellular signaling of apoptosis and inflammation. Annu. Rev. Immunol. 25:561-86
28. Aravind L, Dixit VM, Koonin EV. 2001. Apoptotic molecular machinery: vastly increased complexity in vertebrates revealed by genome comparisons. Science 291:1279-84
29. Tschopp J, Martinon F, Burns K. 2003. NALPs: a novel protein family involved in inflammation. Nat. Rev. Mol. Cell Biol. 4:95-104
30. Inohara N, Nuñez G. 2003. NODs: intracellular proteins involved in inflammation and apoptosis. Nat. Rev. Immunol. 3:371-82
31. Lich JD, Ting JP. 2007. CATERPILLER (NLR) family members as positive and negative regulators of inflammatory responses. Proc. Am. Thoracic Soc. 4:263-66
32. Proell M, Riedl S, Fritz J, Rojas A, Schwarzenbacher R. 2008. The Nod-like receptor (NLR) family: a tale of similarities and differences. PLoS ONE 3:e2119
33. Martinon F, Tschopp J. 2007. Inflammatory caspases and inflammasomes: master switches of inflammation. Cell Death Differ. 14:10-22
34. Reith W, Mach B. 2001. The bare lymphocyte syndrome and the regulation of MHC expression. Annu. Rev. Immunol. 19:331-73
35. Meylan E, Tschopp J. 2008. NLRX1: friend or foe? EMBO Rep. 9:243-45
36. Moore CB, Bergstralh DT, Duncan JA, Lei Y, Morrison TE, et al. 2008. NLRX1 is a regulator of mitochondrial antiviral immunity. Nature 451:573-77
37. Tattoli I, Carneiro LA, Jéhanno M, Magalhaes JG, Shu Y, et al. 2008. NLRX1 is a mitochondrial NOD-like receptor that amplifies NF-κB and JNK pathways by inducing reactive oxygen species production. EMBO Rep. 9:293-300
38. Vinzing M, Eitel J, Lippmann J, Hocke AC, Zahlten J, et al. 2008. NAIP and Ipaf control Legionella pneumophila replication in human cells. J. Immunol. 180:6808-15
39. Kummer JA, Broekhuizen R, Everett H, Agostini L, Kuijk L, et al. 2007. Inflammasome components NALP 1 and 3 show distinct but separate expression profiles in human tissues suggesting a site-specific role in the inflammatory response. J. Histochem. Cytochem. 55:443-52
40. McCall SH, Sahraei M, Young AB, Worley CS, Duncan JA, et al. 2008. Osteoblasts express NLRP3, a nucleotide-binding domain and leucine-rich repeat region containing receptor implicated in bacterially induced cell death. J. Bone Miner. Res. 23:30-40
41. Poyet JL, Srinivasula SM, Tnani M, Razmara M, Fernandes-Alnemri T, Alnemri ES. 2001. Identification of Ipaf, a human caspase-1-activating protein related to Apaf-1. J. Biol. Chem. 276:28309-13
42. Diez E, Yaraghi Z, MacKenzie A, Gros P. 2000. The neuronal apoptosis inhibitory protein (Naip) is expressed in macrophages and is modulated after phagocytosis and during intracellular infection with Legionella pneumophila. J. Immunol. 164:1470-77
43. McDaniel P, Wu X. 2008. Identification of oocyte-selective NLRP genes in rhesus macaque monkeys (Macaca mulatta). Mol. Reprod. Dev. 76:151-59
44. Becker CE, O'Neill LA. 2007. Inflammasomes in inflammatory disorders: the role of TLRs and their interactions with NLRs. Semin. Immunopathol. 29:239-48
45. Caplan J, Padmanabhan M, Dinesh-Kumar SP. 2008. Plant NB-LRR immune receptors: from recognition to transcriptional reprogramming. Cell Host Microbe 3:126-35
46. Tan X, Meyers BC, Kozik A, West MA, Morgante M, et al. 2007. Global expression analysis of nucleotide binding site-leucine rich repeat-encoding and related genes in Arabidopsis. BMC Plant Biol. 7:56
47. Bent AF, Mackey D. 2007. Elicitors, effectors, and R genes: the new paradigm and a lifetime supply of questions. Annu. Rev. Phytopathol. 45:399-436
48. Ausubel F. 2005. Are innate immune signaling pathways in plants and animals conserved? Nat. Immunol. 6:973-79
49. Staal J, Dixelius C. 2007. Tracing the ancient origins of plant innate immunity. Trends Plant Sci. 12:334-42
50. Tauber AI. 1992. The birth of immunology. III. The fate of the phagocytosis theory. Cell Immunol. 139:505-30
51. Hibino T, Loza-Coll M, Messier C, Majeske AJ, Cohen AH, et al. 2006. The immune gene repertoire encoded in the purple sea urchin genome. Dev. Biol. 300:349-65
52. Rast JP, Smith LC, Loza-Coll M, Hibino T, Litman GW. 2006. Genomic insights into the immune system of the sea urchin. Science 314:952-56
53. Laing K, Purcell M, Winton J, Hansen J. 2008. A genomic view of the NOD-like receptor family in teleost fish: identification of a novel NLR subfamily in zebrafish. BMC Evol. Biol. 8:42
54. Stein C, Caccamo M, Laird G, Leptin M. 2007. Conservation and divergence of gene families encoding components of innate immune response systems in zebrafish. Genome Biol. 8:R251
55. Chae JJ, Wood G, Masters SL, Richard K, Park G, et al. 2006. The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1β production. Proc. Natl. Acad. Sci. USA 103:9982-87
56. Papin S, Cuenin S, Agostini L, Martinon F, Werner S, et al. 2007. The SPRY domain of Pyrin, mutated in familial Mediterranean fever patients, interacts with inflammasome components and inhibits proIL-1β processing. Cell Death Differ. 14:1457-66
57. Lespinet O, Wolf YI, Koonin EV, Aravind L. 2002. The role of lineage-specific gene family expansion in the evolution of Eukaryotes. Genome Res. 12:1048-59
58. Bertin J, Nir WJ, Fischer CM, Tayber OV, Errada PR, et al. 1999. Human CARD4 protein is a novel CED-4/Apaf-1 cell death family member that activates NF-κB. J. Biol. Chem. 274:12955-58
59. Inohara N, Koseki T, del Peso L, Hu Y, Yee C, et al. 1999. Nod1, an Apaf-1-like activator of caspase-9 and nuclear factor-κB. J. Biol. Chem. 274:14560-67
60. Tattoli I, Travassos L, Carneiro LA, Magalhaes J, Girardin S. 2007. The Nodosome: Nod1 and Nod2 control bacterial infections and inflammation. Semin. Immunopathol. 29:289-301
61. Hsu Y, Zhang Y, You Y, Wang D, Li H, et al. 2007. The adaptor protein CARD9 is required for innate immune responses to intracellular pathogens. Nat. Immunol. 8:198-205
62. Mcdonald C, Inohara N, Nunez G. 2005. Peptidoglycan signaling in innate immunity and inflammatory disease. J. Biol. Chem. 280:20177-80
63. Girardin SE, Philpott DJ. 2004. Mini-review: the role of peptidoglycan recognition in innate immunity. Eur. J. Immunol. 34:1777-82
64. Viala J, Chaput C, Boneca I, Cardona A, Girardin SE, et al. 2004. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat. Immunol. 5:1166-74
65. Kobayashi KS, Chamaillard M, Ogura Y, Henegariu O, Inohara N, et al. 2005. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 307:731-34
66. Vignal C, Singer E, Peyrin-Biroulet L, Desreumaux P, Chamaillard M. 2007. How NOD2 mutations predispose to Crohn's disease? Microbes Infect. 9:658-63
67. Tanabe T, Chamaillard M, Ogura Y, Zhu L, Qiu S, et al. 2004. Regulatory regions and critical residues of NOD2 involved in muramyl dipeptide recognition. EMBO J. 23:1587-97
68. Hsu LC, Ali SR, McGillivray S, Tseng PH, Mariathasan S, et al. 2008. A NOD2-NALP1 complex mediates caspase-1-dependent IL-1β secretion in response to Bacillus anthracis infection and muramyl dipeptide. Proc. Natl. Acad. Sci. USA 105:7803-8
69. Pan Q, Mathison J, Fearns C, Kravchenko VV, Da Silva Correia J, et al. 2007. MDP-induced interleukin-1β processing requires Nod2 and CIAS1/NALP3. J. Leukoc. Biol. 82:177-83
70. Martinon F, Burns K, Tschopp J. 2002. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-1β. Mol. Cell 10:417-26
71. Zou H, Li Y, Liu X, Wang X. 1999. An APAF-1.cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J. Biol. Chem. 274:11549-56
72. Cohen GM. 1997. Caspases: the executioners of apoptosis. Biochem. J. 326(Pt. 1):1-16
73. Fuentes-Prior P, Salvesen GS. 2004. The protein structures that shape caspase activity, specificity, activation and inhibition. Biochem. J. 384:201-32
74. Boatright KM, Salvesen GS. 2003. Mechanisms of caspase activation. Curr. Opin. Cell Biol. 15:725-31
75. Nadiri A, Wolinski MK, Saleh M. 2006. The inflammatory caspases: key players in the host response to pathogenic invasion and sepsis. J. Immunol. 177:4239-45
76. Martinon F, Gaide O, Pétrilli V, Mayor A, Tschopp J. 2007. NALP inflammasomes: a central role in innate immunity. Semin. Immunopathol. 29:213-29
77. Mariathasan S, Newton K, Monack DM, Vucic D, French DM, et al. 2004. Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 430:213-18
78. Agostini L, Burns K, McDermott MF, Hawkins PN, Tschopp J. 2004. NALP3 forms an IL-1β-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity 20:319-25
79. Duncan JA, Bergstralh DT, Wang Y, Willingham SB, Ye Z, et al. 2007. Cryopyrin/NALP3 binds ATP/dATP, is an ATPase, and requires ATP binding to mediate inflammatory signaling. Proc. Natl. Acad. Sci. USA 104:8041-46
80. Lu C, Wang A, Wang L, Dorsch M, Ocain TD, Xu Y. 2005. Nucleotide binding to CARD12 and its role in CARD12-mediated caspase-1 activation. Biochem. Biophys. Res. Commun. 331:1114-19
81. Mayor A, Martinon F, De Smedt T, Pétrilli V, Tschopp J. 2007. A crucial function of SGT1 and HSP90 in inflammasome activity links mammalian and plant innate immune responses. Nat. Immunol. 8:497-503
82. Da Silva Correia J, Miranda Y, Leonard N, Ulevitch R. 2007. SGT1 is essential for Nod1 activation. Proc. Natl. Acad. Sci. USA 104:6764-69
83. Chapelsky S, Batty S, Frost M, Mogridge J. 2008. Inhibition of anthrax lethal toxin-induced cytolysis of RAW264.7 cells by celastrol. PLoS ONE 3:e1421
84. Miao EA, Andersen-Nissen E, Warren SE, Aderem A. 2007. TLR5 and Ipaf: dual sensors of bacterial flagellin in the innate immune system. Semin. Immunopathol. 29:275-88
85. Franchi L, Park JH, Shaw MH, Marina-Garcia N, Chen G, et al. 2008. Intracellular NOD-like receptors in innate immunity, infection and disease. Cell Microbiol. 10:1-8
86. Martinon F. 2007. Orchestration of pathogen recognition by inflammasome diversity: variations on a common theme. Eur. J. Immunol. 37:3003-6
87. Matzinger P. 1994. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12:991-1045
88. Rock KL, Kono H. 2008. The inflammatory response to cell death. Annu. Rev. Pathol. 3:99-126
89. Kono H, Rock KL. 2008. How dying cells alert the immune system to danger. Nat. Rev. Immunol. 8:279-89
90. Rock KL, Hearn A, Chen CJ, Shi Y. 2005. Natural endogenous adjuvants. Springer Semin. Immunopathol. 26:231-46
91. Schneider DS. 2002. Plant immunity and film noir: what gumshoe detectives can teach us about plant-pathogen interactions. Cell 109:537-40
92. Kostura MJ, Tocci MJ, Limjuco G, Chin J, Cameron P, et al. 1989. Identification of a monocyte specific preinterleukin 1 β convertase activity. Proc. Natl. Acad. Sci. USA 86:5227-31
93. Pétrilli V, Papin S, Dostert C, Mayor A, Tschopp J. 2007. Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration. Cell Death Differ. 14:1583-89
94. + release. Am. J. Physiol. Cell Physiol. 286:C1100-8
95. + for caspase-1 activation induced by intracellular and extracellular bacteria. J. Biol. Chem. 282:18810-18
96. Mariathasan S, Weiss DS, Newton K, McBride J, O'Rourke K, et al. 2006. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440:228-32
97. Sutterwala FS, Ogura Y, Szczepanik M, Lara-Tejero M, Lichtenberger GS, et al. 2006. Critical role for NALP3/CIAS1/cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity 24:317-27
98. Kanneganti TD, Ozören N, Body-Malapel M, Amer A, Park JH, et al. 2006. Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3. Nature 440:233-36
99. Haag F, Adriouch S, Braß A, Jung C, Möller S, et al. 2007. Extracellular NAD and ATP: partners in immune cell modulation. Purinergic Signal 3:71-81
100. Eckle T, Füllbier L, Wehrmann M, Khoury J, Mittelbronn M, et al. 2007. Identification of ectonucleotidases CD39 and CD73 in innate protection during acute lung injury. J. Immunol. 178:8127-37
101. Communi D, Janssens R, Suarez-Huerta N, Robaye B, Boeynaems JM. 2000. Advances in signalling by extracellular nucleotides: the role and transduction mechanisms of P2Y receptors. Cell Signal. 12:351-60
102. Novak I. 2003. ATP as a signaling molecule: the exocrine focus. News Physiol. Sci. 18:12-17
103. MacDonald PE, Braun M, Galvanovskis J, Rorsman P. 2006. Release of small transmitters through kiss-and-run fusion pores in rat pancreatic beta cells. Cell Metab. 4:283-90
104. Koshlukova SE, Lloyd TL, Araujo MW, Edgerton M. 1999. Salivary histatin 5 induces nonlytic release of ATP from Candida albicans leading to cell death. J. Biol. Chem. 274:18872-79
105. Laliberte RE, Eggler J, Gabel CA. 1999. ATP treatment of human monocytes promotes caspase-1 maturation and externalization. J. Biol. Chem. 274:36944-51
106. Kanneganti TD, Lamkanfi M, Kim YG, Chen G, Park JH, et al. 2007. Pannexin-1-mediated recognition of bacterial molecules activates the cryopyrin inflammasome independent of Toll-like receptor signaling. Immunity 26:433-43
107. Locovei S, Bao L, Dahl GP. 2006. Pannexin 1 in erythrocytes: function without a gap. Proc. Natl. Acad. Sci. USA 103:7655-59
108. Piccini A, Carta S, Tassi S, Lasiglié D, Fossati G, Rubartelli A. 2008. ATP is released by monocytes stimulated with pathogen-sensing receptor ligands and induces IL-1β and IL-18 secretion in an autocrine way. Proc. Natl. Acad. Sci. USA 105:8067-72
109. Yamamoto M, Yaginuma K, Tsutsui H, Sagara J, Guan X, et al. 2004. ASC is essential for LPS-induced activation of procaspase-1 independently of TLR-associated signal adaptor molecules. Genes Cells 9:1055-67
110. Idzko M, Hammad H, van Nimwegen M, Kool M, Willart MA, et al. 2007. Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells. Nat. Med. 13:913-19
111. Shi Y, Evans JE, Rock KL. 2003. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 425:516-21
112. Chen CJ, Shi Y, Hearn A, Fitzgerald K, Golenbock D, et al. 2006. MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals. J. Clin. Invest. 116:2262-71
113. Eisenbarth SC, Colegio OR, O'Connor W, Sutterwala FS, Flavell RA. 2008. Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature 453:1122-26
114. Shi Y, Galusha SA, Rock KL. 2006. Cutting edge: elimination of an endogenous adjuvant reduces the activation of CD8T lymphocytes to transplanted cells and in an autoimmune diabetes model. J. Immunol. 176:3905-8
115. Orengo J, Evans J, Bettiol E, Leliwa-Sytek A, Day K, et al. 2008. Plasmodium-induced inflammation by uric acid. PLoS Pathogens 4:e1000013
116. Kool M, Soullié T, Van Nimwegen M, Willart MA, Muskens F, et al. 2008. Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells. J. Exp. Med. 205:869-82
117. Li H, Willingham SB, Ting JP, Re F. 2008. Cutting edge: inflammasome activation by alum and alum's adjuvant effect are mediated by NLRP3. J. Immunol. 181:17-21
118. Franchi L, Núñez G. 2008. The Nlrp3 inflammasome is critical for aluminium hydroxide-mediated IL-1β secretion but dispensable for adjuvant activity. Eur. J. Immunol. 38:2085-89
119. Kool M, Pétrilli V, De Smedt T, Rolaz A, Hammad H, et al. 2008. Alum adjuvant stimulates inflammatory dendritic cells through activation of the NALP3 inflammasome. J. Immunol. 205:869-82
120. Kutzing MK, Firestein BL. 2008. Altered uric acid levels and disease states. J. Pharmacol. Exp. Ther. 324:1-7
121. Lioté F, Ea HK. 2007. Recent developments in crystal-induced inflammation pathogenesis and management. Curr. Rheumatol. Rep. 9:243-50
122. So A, De Smedt T, Revaz S, Tschopp J. 2007. A pilot study of IL-1 inhibition by anakinra in acute gout. Arthritis Res. Ther. 9:R28
123. McGonagle D, Tan A, Shankaranarayana S, Madden J, Emery P, McDermott M. 2007. Management of treatment resistant inflammation of acute or chronic tophaceous gout with anakinra. Ann. Rheum. Dis. 66:1683-84
124. McGonagle D, Tan AL, Madden J, Emery P, McDermott MF. 2008. Successful treatment of resistant pseudogout with anakinra. Arthritis Rheum. 58:631-33
125. Otsuki T, Maeda M, Murakami S, Hayashi H, Miura Y, et al. 2007. Immunological effects of silica and asbestos. Cell Mol. Immunol. 4:261-68
126. Wagner GR. 1997. Asbestosis and silicosis. Lancet 349:1311-15
127. Dostert C, Petrilli V, van Bruggen R, Steele C, Mossman BT, Tschopp J. 2008. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 320:674-77
128. Cassel SL, Eisenbarth SC, Iyer SS, Sadler JJ, Colegio OR, et al. 2008. The Nalp3 inflammasome is essential for the development of silicosis. Proc. Natl. Acad. Sci. USA 105:9035-40
129. Hornung V, Bauernfeind F, Halle A, Samstad EO, Kono H, et al. 2008. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat. Immunol. 9:847-56
130. McKee AS, Munks MW, Marrack P. 2007. How do adjuvants work? Important considerations for new generation adjuvants. Immunity 27:687-90
131. Lindblad EB. 2004. Aluminium compounds for use in vaccines. Immunol. Cell Biol. 82:497-505
132. Mannhalter JW, Neychev HO, Zlabinger GJ, Ahmad R, Eibl MM. 1985. Modulation of the human immune response by the nontoxic and nonpyrogenic adjuvant aluminium hydroxide: effect on antigen uptake and antigen presentation. Clin. Exp. Immunol. 61:143-51
133. Grun JL, Maurer PH. 1989. Different T helper cell subsets elicited in mice utilizing two different adjuvant vehicles: the role of endogenous interleukin 1 in proliferative responses. Cell Immunol. 121:134-45
134. Li H, Nookala S, Re F. 2007. Aluminum hydroxide adjuvants activate caspase-1 and induce IL-1β and IL-18 release. J. Immunol. 178:5271-76
135. Feldmeyer L, Keller M, Niklaus G, Hohl D, Werner S, Beer HD. 2007. The inflammasome mediates UVB-induced activation and secretion of interleukin-1β by keratinocytes. Curr. Biol. 17:1140-45
136. Cavani A, De Pità O, Girolomoni G. 2007. New aspects of the molecular basis of contact allergy. Curr. Opin. Allergy Clin. Immunol. 7:404-8
137. Shornick LP, De Togni P, Mariathasan S, Goellner J, Strauss-Schoenberger J, et al. 1996. Mice deficient in IL-1β manifest impaired contact hypersensitivity to trinitrochlorobenzone. J. Exp. Med. 183:1427-36
138. Zepter K, Häffner A, Soohoo LF, De Luca D, Tang HP, et al. 1997. Induction of biologically active IL-1β-converting enzyme and mature IL-1β in human keratinocytes by inflammatory and immunologic stimuli. J. Immunol. 159:6203-8
139. Antonopoulos C, Cumberbatch M, Dearman RJ, Daniel RJ, Kimber I, Groves RW. 2001. Functional caspase-1 is required for Langerhans cell migration and optimal contact sensitization in mice. J. Immunol. 166:3672-77
140. Wang B, Feliciani C, Howell BG, Freed I, Cai Q, et al. 2002. Contribution of Langerhans cell-derived IL-18 to contact hypersensitivity. J. Immunol. 168:3303-8
141. Watanabe H, Gaide O, Pétrilli V, Martinon F, Contassot E, et al. 2007. Activation of the IL-1β-processing inflammasome is involved in contact hypersensitivity. J. Invest. Dermatol. 127:1956-63
142. Yazdi AS, Ghoreschi K, Röcken M. 2007. Inflammasome activation in delayed-type hypersensitivity reactions. J. Investig. Dermatol. 127:1853-55
143. Watanabe H, Gehrke S, Contassot E, Roques S, Tschopp J, et al. 2008. Danger signaling through the inflammasome acts as a master switch between tolerance and sensitization. J. Immunol. 180:5826-32
144. Cannon GJ, Swanson JA. 1992. The macrophage capacity for phagocytosis. J. Cell Sci. 101(Pt. 4):907-13
145. Khandani A, Eng E, Jongstra-Bilen J, Schreiber AD, Douda D, et al. 2007. Microtubules regulate PI-3K activity and recruitment to the phagocytic cup during Fcγ receptor-mediated phagocytosis in nonelicited macrophages. J. Leukoc. Biol. 82:417-28
146. Nuki G, Simkin PA. 2006. A concise history of gout and hyperuricemia and their treatment. Arthritis Res. Ther. 8(Suppl. 1):S1
147. Fubini B, Hubbard A. 2003. Reactive oxygen species (ROS) and reactive nitrogen species (RNS) generation by silica in inflammation and fibrosis. Free Radic. Biol. Med. 34:1507-16
148. Simeonova PP, Luster MI. 1995. Iron and reactive oxygen species in the asbestos-induced tumor necrosis factor-α response from alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 12:676-83
149. Cruz CM, Rinna A, Forman HJ, Ventura AL, Persechini PM, Ojcius DM. 2007. ATP activates a reactive oxygen species-dependent oxidative stress response and secretion of proinflammatory cytokines in macrophages. J. Biol. Chem. 282:2871-79
150. Bossi O, Gartsbein M, Leitges M, Kuroki T, Grossman S, Tennenbaum T. 2008. UV irradiation increases ROS production via PKCδ signaling in primary murine fibroblasts. J. Cell Biochem. 105:194-207.
151. Rutault K, Alderman C, Chain BM, Katz DR. 1999. Reactive oxygen species activate human peripheral blood dendritic cells. Free Radic. Biol. Med. 26:232-38
152. Bolwell GP. 1999. Role of active oxygen species and NO in plant defence responses. Curr. Opin. Plant Biol. 2:287-94
153. Fay AJ, Qian X, Jan YN, Jan LY. 2006. SK channels mediate NADPH oxidase-independent reactive oxygen species production and apoptosis in granulocytes. Proc. Natl. Acad. Sci. USA 103:17548-53
154. Ishii KJ, Koyama S, Nakagawa A, Coban C, Akira S. 2008. Host innate immune receptors and beyond: making sense of microbial infections. Cell Host Microbe 3:352-63
155. Freche B, Reig N, Van Der Goot FG. 2007. The role of the inflammasome in cellular responses to toxins and bacterial effectors. Semin. Immunopathol. 29:249-60
156. Brown N, Wickham M, Coombes B, Finlay BB. 2006. Crossing the line: selection and evolution of virulence traits. PLoS Pathog. 2:e42
157. Strominger JL. 2007. Bacterial cell walls, innate immunity and immunoadjuvants. Nat. Immunol. 8:1269-71
158. Oppenheim JJ, Togawa A, Chedid L, Mizel S. 1980. Components of mycobacteria and muramyl dipeptide with adjuvant activity induce lymphocyte activating factor. Cell Immunol. 50:71-81
159. Martinon F, Agostini L, Meylan E, Tschopp J. 2004. Identification of bacterial muramyl dipeptide as activator of the NALP3/cryopyrin inflammasome. Curr. Biol. 14:1929-34
160. Marina-Garcia N, Franchi L, Kim Y, Miller D, Mcdonald C, et al. 2008. Pannexin-1-mediated intracellular delivery of muramyl dipeptide induces caspase-1 activation via cryopyrin/NLRP3 independently of Nod2. J. Immunol. 180:4050-57
161. Nagao S, Akagawa KS, Yamada K, Yagawa K, Tokunaga T, Kotani S. 1990. Lack of response of murine peritoneal macrophages to in vitro activation by muramyl dipeptide (MDP). I. Macrophage activation by MDP is species dependent. Microbiol. Immunol. 34:323-35
162. Staruch MJ, Wood DD. 1982. Genetic influences on the adjuvanticity of muramyl dipeptide in vivo. J. Immunol. 128:155-60
163. Ferwerda G, Kramer M, de Jong D, Piccini A, Joosten LA, et al. 2008. Engagement of NOD2 has a dual effect on proIL-1β mRNA transcription and secretion of bioactive IL-1β. Eur. J. Immunol. 38:184-91
164. Maeda S, Hsu LC, Liu H, Bankston LA, Iimura M, et al. 2005. Nod2 mutation in Crohn's disease potentiates NF-κB activity and IL-1β processing. Science 307:734-38
165. Bruey JM, Bruey-Sedano N, Luciano F, Zhai D, Balpai R, et al. 2007. Bcl-2 and Bcl-XL regulate proinflammatory caspase-1 activation by interaction with NALP1. Cell 129:45-56
166. Takaoka A, Wang Z, Choi MK, Yanai H, Negishi H, et al. 2007. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 448:501-5
167. Kumagai Y, Takeuchi O, Akira S. 2008. TLR9 as a key receptor for the recognition of DNA. Adv. Drug Deliv. Rev. 60:795-804
168. Muruve DA, Pétrilli V, Zaiss AK, White LR, Clark SA, et al. 2008. The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response. Nature 452:103-7
169. Kanneganti TD, Body-Malapel M, Amer A, Park JH, Whitfield J, et al. 2006. Critical role for Cryopyrin/Nalp3 in activation of caspase-1 in response to viral infection and double-stranded RNA. J. Biol. Chem. 281:36560-68
170. Gonzalez MR, Bischofberger M, Pernot L, Van Der Goot FG, Frêche B. 2008. Bacterial pore-forming toxins: the (w)hole story? Cell Mol. Life Sci. 65:493-507
171. Gurcel L, Abrami L, Girardin S, Tschopp J, Van Der Goot FG. 2006. Caspase-1 activation of lipid metabolic pathways in response to bacterial pore-forming toxins promotes cell survival. Cell 126:1135-45
172. Ozören N, Masumoto J, Franchi L, Kanneganti TD, Body-Malapel M, et al. 2006. Distinct roles of TLR2 and the adaptor ASC in IL-1β/IL-18 secretion in response to Listeria monocytogenes. J. Immunol. 176:4337-42
173. Hara H, Tsuchiya K, Nomura T, Kawamura I, Shoma S, Mitsuyama M. 2008. Dependency of caspase-1 activation induced in macrophages by Listeria monocytogenes on cytolysin, listeriolysin O, after evasion from phagosome into the cytoplasm. J. Immunol. 180:7859-68
174. Warren SE, Mao DP, Rodriguez AE, Miao EA, Aderem A. 2008. Multiple Nod-like receptors activate caspase 1 during Listeria monocytogenes infection. J. Immunol. 180:7558-64
175. Boyden E, Dietrich W. 2006. Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin. Nat. Genet. 38:240-44
176. Fink SL, Bergsbaken T, Cookson BT. 2008. Anthrax lethal toxin and Salmonella elicit the common cell death pathway of caspase-1-dependent pyroptosis via distinct mechanisms. Proc. Natl. Acad. Sci. USA 105:4312-17
177. Wickliffe KE, Leppla SH, Moayeri M. 2008. Anthrax lethal toxin-induced inflammasome formation and caspase-1 activation are late events dependent on ion fluxes and the proteasome. Cell Microbiol. 10:332-43
178. Squires RC, Muehlbauer SM, Brojatsch J. 2007. Proteasomes control caspase-1 activation in anthrax lethal toxin-mediated cell killing. J. Biol. Chem. 282:34260-67
179. Lara-Tejero M, Sutterwala FS, Ogura Y, Grant EP, Bertin J, et al. 2006. Role of the caspase-1 inflammasome in Salmonella typhimurium pathogenesis. J. Exp. Med. 203:1407-12
180. Molofsky AB, Byrne BG, Whitfield NN, Madigan CA, Fuse ET, et al. 2006. Cytosolic recognition of flagellin by mouse macrophages restricts Legionella pneumophila infection. J. Exp. Med. 203:1093-104
181. Ren T, Zamboni DS, Roy CR, Dietrich W, Vance RE. 2006. Flagellin-deficient Legionella mutants evade caspase-1- and Naip5-mediated macrophage immunity. PLoS Pathog. 2:e18
182. Zamboni DS, Kobayashi KS, Kohlsdorf T, Ogura Y, Long EM, et al. 2006. The Birc1e cytosolic pattern-recognition receptor contributes to the detection and control of Legionella pneumophila infection. Nat. Immunol. 7:318-25
183. Lamkanfi M, Amer A, Kanneganti TD, Muñoz-Planillo R, Chen G, et al. 2007. The Nod-like receptor family member Naip5/Birc1e restricts Legionella pneumophila growth independently of caspase-1 activation. J. Immunol. 178:8022-27
184. Pedra JH, Sutterwala FS, Sukumaran B, Ogura Y, Qian F, et al. 2007. ASC/PYCARD and caspase-1 regulate the IL-18/IFN-γ axis during Anaplasma phagocytophilum infection. J. Immunol. 179:4783-91
185. Miao EA, Ernst RK, Dors M, Mao DP, Aderem A. 2008. Pseudomonas aeruginosa activates caspase 1 through Ipaf. Proc. Natl. Acad. Sci. USA 105:2562-67
186. Sutterwala FS, Mijares LA, Li L, Ogura Y, Kazmierczak BI, Flavell RA. 2007. Immune recognition of Pseudomonas aeruginosa mediated by the IPAF/NLRC4 inflammasome. J. Exp. Med. 204:3235-45
187. Franchi L, Stoolman J, Kanneganti TD, Verma A, Ramphal R, Núñez G. 2007. Critical role for Ipaf in Pseudomonas aeruginosa-induced caspase-1 activation. Eur. J. Immunol. 37:3030-39
188. Suzuki T, Franchi L, Toma C, Ashida H, Ogawa M, et al. 2007. Differential regulation of caspase-1 activation, pyroptosis, and autophagy via Ipaf and ASC in Shigella-infected macrophages. PLoS Pathog. 3:e111
189. Henry T, Brotcke A, Weiss DS, Thompson LJ, Monack DM. 2007. Type I interferon signaling is required for activation of the inflammasome during
190. Greten FR, Arkan MC, Bollrath J, Hsu LC, Goode J, et al. 2007. NF-κB is a negative regulator of IL-1β secretion as revealed by genetic and pharmacological inhibition of IKKβ. Cell 130:918-31
191. Stehlik C, Dorfleutner A. 2007. COPs and POPs: Modulators of inflammasome activity. J. Immunol. 179:7993-98
192. Dorfleutner A, Talbott SJ, Bryan NB, Funya KN, Rellick SL, et al. 2007. A Shope Fibroma virus PYRIN-only protein modulates the host immune response. Virus Genes 35:685-94
193. Benedict CA, Ware CF. 2005. Poxviruses aren't stuPYD. Immunity 23:553-55
194. Johnston JB, Barrett JW, Nazarian SH, Goodwin M, Ricciuto D, et al. 2005. A poxvirus-encoded pyrin domain protein interacts with ASC-1 to inhibit host inflammatory and apoptotic responses to infection. Immunity 23:587-98
195. Bedoya F, Sandler LL, Harton JA. 2007. Pyrin-only protein 2 modulates NF-κB and disrupts ASC:CLR interactions. J. Immunol. 178:3837-45
196. The French FMF Consortium. 1997. A candidate gene for familial Mediterranean fever. Nat. Genet. 17:25-31
197. Chae JJ, Komarow HD, Cheng J, Wood G, Raben N, et al. 2003. Targeted disruption of pyrin, the FMF protein, causes heightened sensitivity to endotoxin and a defect in macrophage apoptosis. Mol. Cell 11:591-604
198. Fernandes-Alnemri T, Wu J, Yu JW, Datta P, Miller B, et al. 2007. The pyroptosome: a supramolecular assembly of ASC dimers mediating inflammatory cell death via caspase-1 activation. Cell Death Differ. 14:1590-604
199. McDermott MF. 2004. A common pathway in periodic fever syndromes. Trends Immunol. 25:457-60
200. Shoham NG, Centola M, Mansfield E, Hull KM, Wood G, et al. 2003. Pyrin binds the PSTPIP1/CD2BP1 protein, defining familial Mediterranean fever and PAPA syndrome as disorders in the same pathway. Proc. Natl. Acad. Sci. USA 100:13501-6
201. Grosse J, Chitu V, Marquardt A, Hanke P, Schmittwolf C, et al. 2006. Mutation of mouse Mayp/Pstpip2 causes a macrophage autoinflammatory disease. Blood 107:3350-58
202. Ferguson PJ, Bing X, Vasef MA, Ochoa LA, Mahgoub A, et al. 2006. A missense mutation in pstpip2 is associated with the murine autoinflammatory disorder chronic multifocal osteomyelitis. Bone 38:41-47
203. da Cunha JP, Galante PA, de Souza SJ. 2008. Different evolutionary strategies for the origin of caspase-1 inhibitors. J. Mol. Evol. 66:591-97
204. Kersse K, Vanden Berghe T, Lamkanfi M, Vandenabeele P. 2007. Aphylogenetic and functional overview of inflammatory caspases and caspase-1-related CARD-only proteins. Biochem. Soc. Trans. 35:1508-11
205. Saleh M, Vaillancourt JP, Graham RK, Huyck M, Srinivasula SM, et al. 2004. Differential modulation of endotoxin responsiveness by human caspase-12 polymorphisms. Nature 429:75-79
206. Kachapati K, O'Brien TR, Bergeron J, Zhang M, Dean M. 2006. Population distribution of the functional caspase-12 allele. Hum. Mutat. 27:975
207. Wang X, Grus W, Zhang J. 2006. Gene losses during human origins. PLoS Biol. 4:e52
208. Xue Y, Daly A, Yngvadottir B, Liu M, Coop G, et al. 2006. Spread of an inactive form of caspase-12 in humans is due to recent positive selection. Am. J. Hum. Genet. 78:659-70
209. Saleh M, Mathison JC, Wolinski MK, Bensinger SJ, Fitzgerald P, et al. 2006. Enhanced bacterial clearance and sepsis resistance in caspase-12-deficient mice. Nature 440:1064-68
210. Roy S, Sharom JR, Houde C, Loisel TP, Vaillancourt JP, et al. 2008. Confinement of caspase-12 proteolytic activity to autoprocessing. Proc. Natl. Acad. Sci. USA 105:4133-38
211. Miggin SM, Pålsson-McDermott E, Dunne A, Jefferies C, Pinteaux E, et al. 2007. NF-κB activation by the Toll-IL-1 receptor domain protein MyD88 adapter-like is regulated by caspase-1. Proc. Natl. Acad. Sci. USA 104:3372-77
212. Keller M, Rüegg A, Werner S, Beer HD. 2008. Active caspase-1 is a regulator of unconventional protein secretion. Cell 132:818-31
213. Chae JJ, Wood G, Richard K, Jaffe H, Colburn NT, et al. 2008. The familial Mediterranean fever protein, pyrin, is cleaved by caspase-1 and activates NF-κB through its N-terminal fragment. Blood 112:1794-803
214. Dinarello CA. 2004. Infection, fever, and exogenous and endogenous pyrogens: some concepts have changed. J. Endotoxin Res. 10:201-22
215. Samad TA, Moore KA, Sapirstein A, Billet S, Allchorne A, et al. 2001. Interleukin-1β-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 410:471-75
216. McGonagle D, Savic S, McDermott MF. 2007. The NLR network and the immunological disease continuum of adaptive and innate immune-mediated inflammation against self. Semin. Immunopathol. 29:303-13
217. McGonagle D, McDermott MF. 2006. A proposed classification of the immunological diseases. PLoS Med. 3:e297
218. Aksentijevich I, Putnam CD, Remmers EF, Mueller JL, Le J, et al. 2007. The clinical continuum of cryopyrinopathies: novel CIAS1 mutations in North American patients and a new cryopyrin model. Arthritis Rheum. 56:1273-85
219. Shinkai K, McCalmont TH, Leslie KS. 2008. Cryopyrin-associated periodic syndromes and autoinflammation. Clin. Exp. Dermatol. 33:1-9
220. Masters SL, Lobito AA, Chae J, Kastner DL. 2006. Recent advances in the molecular pathogenesis of hereditary recurrent fevers. Curr. Opin. Allergy Clin. Immunol. 6:428-33
221. Dowds TA, Masumoto J, Zhu L, Inohara N, Núñez G. 2004. Cryopyrin-induced interleukin 1β secretion in monocytic cells: enhanced activity of disease-associated mutants and requirement for ASC. J. Biol. Chem. 279:21924-28
222. Goldbach-Mansky R, Dailey NJ, Canna SW, Gelabert A, Jones J, et al. 2006. Neonatal-onset multisystem inflammatory disease responsive to interleukin-1β inhibition. N. Engl. J. Med. 355:581-92
223. Hawkins PN, Lachmann HJ, Aganna E, McDermott MF. 2004. Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra. Arthritis Rheum. 50:607-12
224. Hawkins PN, Lachmann HJ, McDermott MF. 2003. Interleukin-1-receptor antagonist in the Muckle-Wells syndrome. N. Engl. J. Med. 348:2583-84
225. Hoffman HM, Rosengren S, Boyle DL, Cho JY, Nayar J, et al. 2004. Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist. Lancet 364:1779-85
226. McDermott MF, Tschopp J. 2007. From inflammasomes to fevers, crystals and hypertension: how basic research explains inflammatory diseases. Trends Mol. Med. 13:381-88
227. Gavin AL, Hoebe K, Duong B, Ota T, Martin C, et al. 2006. Adjuvant-enhanced antibody responses in the absence of Toll-like receptor signaling. Science 314:1936-38
228. Rao DA, Tracey KJ, Pober JS. 2007. IL-1α and IL-1β are endogenous mediators linking cell injury to the adaptive alloimmune response. J. Immunol. 179:6536-46
229. Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F. 2007. Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17-producing human T helper cells. Nat. Immunol. 8:942-49
230. Chedid L. 1985. Adjuvants of immunity. Ann. Inst. Pasteur Immunol. 136D:283-91
231. Misson P, Brombacher F, Delos M, Lison D, Huaux F. 2007. Type 2 immune response associated with silicosis is not instrumental in the development of the disease. Am. J. Physiol. Lung Cell Mol. Physiol. 292:L107-13
232. Helmby H, Grencis R. 2004. Interleukin 1 plays a major role in the development of Th2-mediated immunity. Eur. J. Immunol. 34:3674-81
233. Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, et al. 2005. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23:479-90
234. Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H. 2001. Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu. Cytokine Growth Factor Rev. 12:53-72
235. Jin Y, Mailloux CM, Gowan K, Riccardi SL, LaBerge G, et al. 2007. NALP1 in vitiligo-associated multiple autoimmune disease. N. Engl. J. Med. 356:1216-25
236. Fink SL, Cookson BT. 2005. Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells. Infect. Immun. 73:1907-16
237. Zychlinsky A, Prevost MC, Sansonetti PJ. 1992. Shigella flexneri induces apoptosis in infected macrophages. Nature 358:167-69
238. Chen Y, Smith MR, Thirumalai K, Zychlinsky A. 1996. A bacterial invasin induces macrophage apoptosis by binding directly to ICE. EMBO J. 15:3853-60
239. Hilbi H, Moss JE, Hersh D, Chen Y, Arondel J, et al. 1998. Shigella-induced apoptosis is dependent on caspase-1 which binds to IpaB. J. Biol. Chem. 273:32895-900
240. Hersh D, Monack DM, Smith MR, Ghori N, Falkow S, Zychlinsky A. 1999. The Salmonella invasin SipB induces macrophage apoptosis by binding to caspase-1. Proc. Natl. Acad. Sci. USA 96:2396-401
241. Mariathasan S, Weiss DS, Dixit VM, Monack DM. 2005. Innate immunity against Francisella tularensis is dependent on the ASC/caspase-1 axis. J. Exp. Med. 202:1043-49
242. Cervantes J, Nagata T, Uchijima M, Shibata K, Koide Y. 2008. Intracytosolic Listeria monocytogenes induces cell death through caspase-1 activation in murine macrophages. Cell Microbiol. 10:41-52
243. Reig N, Jiang A, Couture R, Sutterwala FS, Ogura Y, et al. 2008. Maturation modulates caspase-1-independent responses of dendritic cells to Anthrax lethal toxin. Cell Microbiol. 10:1190-207
244. Yu JW, Fernandes-Alnemri T, Datta P, Wu J, Juliana C, et al. 2007. Pyrin activates the ASC pyroptosome in response to engagement by autoinflammatory PSTPIP1 mutants. Mol. Cell 28:214-27
245. Scott AM, Saleh M. 2007. The inflammatory caspases: guardians against infections and sepsis. Cell Death Differ. 14:23-31
246. Simi A, Tsakiri N, Wang P, Rothwell NJ. 2007. Interleukin-1 and inflammatory neurodegeneration. Biochem. Soc. Trans. 35:1122-26
247. McConnell B, Vertino P. 2004. TMS1/ASC: the cancer connection. Apoptosis 9:5-18
248. Trendelenburg G. 2008. Acute neurodegeneration and the inflammasome: central processor for danger signals and the inflammatory response? J. Cereb. Blood Flow Metab. 28:867-81
249. Roy N, Mahadevan MS, McLean M, Shutler G, Yaraghi Z, et al. 1995. The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell 80:167-78
250. Halle A, Hornung V, Petzold GC, Stewart CR, Monks BG, et al. 2008. The NALP3 inflammasome is involved in the innate immune response to amyloid-β. Nat. Immunol. 9:857-65
251. Gérard N, Caillaud M, Martoriati A, Goudet G, Lalmanach AC. 2004. The interleukin-1 system and female reproduction. J. Endocrinol. 180:203-12
252. Caillaud M, Duchamp G, Gérard N. 2005. In vivo effect of interleukin-1β and interleukin-1RA on oocyte cytoplasmic maturation, ovulation, and early embryonic development in the mare. Reprod. Biol. Endocrinol. 3:26
253. Takehara Y, Dharmarajan AM, Kaufman G, Wallach EE. 1994. Effect of interleukin-1 β on ovulation in the in vitro perfused rabbit ovary. Endocrinology 134:1788-93
254. Tong ZB, Gold L, Pfeifer KE, Dorward H, Lee E, et al. 2000. Mater, a maternal effect gene required for early embryonic development in mice. Nat. Genet. 26:267-68
255. Qian J, Deveault C, Bagga R, Xie X, Slim R. 2007. Women heterozygous for NALP7/NLRP7 mutations are at risk for reproductive wastage: report of two novel mutations. Hum. Mutat. 28:741
256. Slim R, Mehio A. 2007. The genetics of hydatidiform moles: new lights on an ancient disease. Clin. Genet. 71:25-34
257. Murdoch S, Djuric U, Mazhar B, Seoud M, Khan R, et al. 2006. Mutations in NALP7 cause recurrent hydatidiform moles and reproductive wastage in humans. Nat. Genet. 38:300-2
258. Shao W, Yeretssian G, Doiron K, Hussain SN, Saleh M. 2007. The caspase-1 digestome identifies the glycolysis pathway as a target during infection and septic shock. J. Biol. Chem. 282:36321-29
259. Li J, Yin HL, Yuan J. 2008. Flightless-I regulates proinflammatory caspases by selectively modulating intracellular localization and caspase activity. J. Cell Biol. 181:321-33
260. Young JL, Sukhova GK, Foster D, Kisiel W, Libby P, Schönbeck U. 2000. The serpin proteinase inhibitor 9 is an endogenous inhibitor of interleukin 1β-converting enzyme (caspase-1) activity in human vascular smooth muscle cells. J. Exp. Med. 191:1535-44
261. Ray CA, Black RA, Kronheim SR, Greenstreet TA, Sleath PR, et al. 1992. Viral inhibition of inflammation: cowpox virus encodes an inhibitor of the interleukin-1 β converting enzyme. Cell 69:597-604